Complement (original) (raw)

• Sunyer JO, Lambris JD Evolution and diversity of the complement system of poikilothermic vertebrates. Immunol Rev 1998;166: 39–57.
  Article PubMed CAS Google Scholar
• Lambris JD, ed. The third component of complement: chemistry and biology. Curr Topics Microb Immunol 1990;153:45–72.
• Volanakis JE: Overview of the complement system: in (Volanakis JE, Frank M, eds) The Human Complements System in Healthand Disease Marcel Dekker Inc. 1998, pp. 9–32.
• Dempsey PW, Allison MD, Akkaraju S, et al.: C3d of complment as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348–350.
  Article PubMed CAS Google Scholar
• Lambris JD: The multifunctional role of C3, the third component of complement. Immunol Today 1988;9:387–393.
  Article PubMed CAS Google Scholar
• Muller-Eberhard HJ: Molecular organization and function of the complement system. Annu Rev Biochem 1988;57:321–347.
  Article PubMed CAS Google Scholar
• Lambris JD, Sahu A, Wetsel R: (1988) The chemistry and biology of C3, C4, and C5; in Volanakis JE, Frank M, (eds) The Human Complement System in Health and Disease, Marcel Dekker Inc., 1998, pp. 83–118.
• Perkins SJ, Sim RB: Molecular modelling of human complement component C3 and its fragments by solution scattering. Eur J Biochem 1986;157:155–168.
  Article PubMed CAS Google Scholar
• Wetsel RA: Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 1995;7:48–53.
  Article PubMed CAS Google Scholar
• Alsenz J, Avila D, Huemer HP, et al.: Phylogeny of the third component of complement, C3: Analysis of the conservation of human CR1, CR2, H, and B bindingsites, concanavalin A binding sites, and thiolester bond in the C3 from different species. Develop Compar Immunol 1992;16:63–76.
  Article CAS Google Scholar
• Lambris JD, Alsenz J, Schulz TF, et al.: Mapping of the properdin-binding site in the third component of complement. Biochem J 1984; 217:323–326.
  PubMed CAS Google Scholar
• Lambris JD, Lao Z, Oglesby TJ, et al.: Dissection of CR1, factor H, MCP, and factor B binding and functional sites in third complement component. J Immunol 1996;156:4821–4832.
  PubMed CAS Google Scholar
• Mastellos D, Lambris JD: Complement: more than a ‘guard’ against invading pathogens? Trends Immunol 2002;23: 485–491.
  Article PubMed CAS Google Scholar
• DiScipio RG, Smith CA, Müller-Eberhard HJ, et al.: The activation of human complement component C5 by a fluid phase C5 convertase. J Biol Chem 1983;258: 10,629–10,636.
  CAS Google Scholar
• Morgan BP: Regulation of the complement membrane attack pathway. Crit Rev Immunol 1999; 19:173–198.
  PubMed CAS Google Scholar
• Halperin JA, Taratuska A, Nicholsonweller A: Terminal Complement Complex C5b-9 Stimulates Mitogenesis in 3T3 Cells. J Clin Invest 1993;91:1974–1978.
  Article PubMed CAS Google Scholar
• Szakonyi G, Guthridge JM, Li D, et al.: Structure of complement receptor 2 in complex with its C3 d ligand. Science 2001;292: 1725–1728.
  Article PubMed CAS Google Scholar
• Nagar B, Jones RG, Diefenbach RJ, et al.: X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2. Science 1998;280:1277–1281.
  Article PubMed CAS Google Scholar
• Clemenza L, Isenman DE: Structure-guided identification of C 3d residues essential for rits binding to complement receptor 2 (CD 21). J Immunol 2000;165: 3839–3848.
  PubMed CAS Google Scholar
• Guaridge JM, Rakstang JK, Young KA, et al.: Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C 3dg. Biochemistry 2001;40:5931–5941.
  Article CAS Google Scholar
• Guthridge JM, Young K, Gipson MG, et al.: Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface. J Immunol 2001;167:5758–5766.
  PubMed CAS Google Scholar
• Smith DL, Deng YZ, Zhang ZQ: Probing the non-covalent structure of proteins by amide hydrogen exchange and massspectrometry. J Mass Spectrom 1997;32:135–146.
  Article PubMed CAS Google Scholar
• Mandell JG, Falick AM, Komives EA: Identification of protein-protein interfaces by decreasedamide proton solvent accessibility. Proc Natl Acad Sci USA 1998;95: 14,705–14,710.
  Article CAS Google Scholar
• Mandell JG, Falick AM, Komives EA: Measuremen to famide hydrogen exchange by MALDI-TOF mass spectrometry. Anal Chem 1998;70:3987–3995.
  Article PubMed CAS Google Scholar
• Sahu A, Lambris JD: Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology 2000;49:133–148.
  Article PubMed CAS Google Scholar
• Sahu A, Lambris JD: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunological Reviews 2001;180:35–48.
  Article PubMed CAS Google Scholar
• Sahu A, Kay BK, Lambris JD: Inhibition of human complement by a C3-binding peptide isolated from a phage displayed random peptide library. J Immunol 1996;157: 884–891.
  PubMed CAS Google Scholar
• Soulika AM, Khan MM, Hattori T, et al.: Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol 2000;96: 212–221.
  Article PubMed CAS Google Scholar
• Fiane AE, Mollnes TE, Videm V, et al.: Prolongation of ex vivoperfused pig xenograft survival by the complement inhibitor complstatin. Trans plant Proc 1999;31: 934–935.
  CAS Google Scholar
• Fiane AE, Mollnes TE, Videm V, et al.: Compstatin, a peptide inhibitor of C3, prolongs survival of exvivo perfused pig xenografts. Xenotransplantation 1999;6: 52–65.
  Article PubMed CAS Google Scholar
• Fiane AE, Videm V, Lambris JD, et al.: Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcineto-human xenograft model. Transplant Proc 2000;32:899–900.
  Article PubMed CAS Google Scholar
• Nilsson B, Larsson R, Hong J, et al.: Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 1998;92:1661–1667.
  PubMed CAS Google Scholar
• Furlong ST, Dutta AS, Coath MM, et al.: O3 activation is inhibited by analogs of compastatin but not by serine protease inhibitors or peptidyl alphaketoheterocycles. Immunopharmacology 2000;48: 199–212.
  Article PubMed CAS Google Scholar
• Morikis D, Assa-Munt N, Sahu A, et al.: Solution structure of compstatin, a potent complement inhibitor. Protein Science 1998; 7:619–627.
  Article PubMed CAS Google Scholar
• Klepeis JL, Floudas CA, Morikis D, et al.: Predicting peptide structures using NMR data and deterministic global optimization. J Comput Chem 1999;20: 1344–1370.
  Google Scholar
• Morikis, D, Sahu A, Moore WT, et al.: Design, structure, function and application of compstatin in bioactive peptides in drug discovery and design: medicalaspects, 1999; 235–246.
• Morikis D, Roy M, Sahu A, et al.: The structural basis of compstatin activity examined by structure-function-based design of peptide analogs and NMR. J Biol Chem 2002;277:14,942–14,953.
  Article CAS Google Scholar
• Sahu A, Soulika AM, Morikis D, et al.: Binding kinetics, structure-activity relationship, and biotrans-formation of the complement inhibitor compastatin. J Immunol 2000;165:2491–2499.
  PubMed CAS Google Scholar
• Lambris JD, Holers VM (eds): Therapeutic interventions in the complement system. Totowa, NJ. Humana, 2000.
  Google Scholar
• Sahu A, Morikis D, Lambris JD: Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C 3. Mol Immunol 2003;39:557–566.
  Article PubMed CAS Google Scholar
• Pennington SR, Wilkins MR, Hochstrasser DF, et al.: Proteome analysis: From protein characterization to biological function. Trends Cell Biol 1997;7:168–173.
  Article CAS PubMed Google Scholar
• Anderson L, Seilhamer: A comparison of selected mRNA and liver. Electrophoresis 1997;18:533–537.
  Article PubMed CAS Google Scholar
• Peng JM, Gygi SP: Proteomics: the move to mixtures. J Mass Spectrom 2001;36:1083–1091.
  Article PubMed CAS Google Scholar
• Mastellos D, Papadimitriou JC, Franchini S, et al.: A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 2001;166: 2479–2486.
  PubMed CAS Google Scholar
• O'Barr SA, Caguioa J, Gruol D, et al.: Neuronal expression of a functional receptor for the C5a complement activation fragment. J Immunol 2001;166:4154–4162.
  PubMed Google Scholar
• Sato T, Abe E, Cheng HJ, et al.: The biological roles of the 3rd component of complementinosteoclast formation. Endocrinology 1993; 133:397–404.
  Article PubMed CAS Google Scholar
• Kotwal GJ, Moss B: Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 1988;335: 176–178.
  Article PubMed CAS Google Scholar
• Kotwal GJ, Isaacs SN, McKenzie R, et al.: Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 1990;250:827–830.
  Article PubMed CAS Google Scholar
• Mckenzie R, Kotwal GJ, Moss B, et al.: Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis 1992;166:1245–1250.
  PubMed CAS Google Scholar
• Sahu A, Isaacs SN, Soulika AM, et al.: Interaction of vaccinia virus complement control protein with human comple ment proteins: Factor I-mediated degradation of C3b to iC3b(1) inactivates the alternative complement pathway. J Immunol 1998;160:5596–5604.
  PubMed CAS Google Scholar
• Saurias MF, Funchini S, Canziani G, et al.: Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J Immunol 2001;167:1490–1499.
  Google Scholar
• Isaacs SF, Kotwal GJ, Moss B: Vaccinia virus complement-control protein prewents antibody-dependent complement-enhanced neutralization of infectivity and contributes to viruence. Proc Natl Acad Sci USA 1982;89:628–632.
  Article Google Scholar
• Albrecht JC, Fleckernstein B: Complement regulatory proteins of herpesivirussaimiri. 1995;127–145.
• Spear PG: Antigenic structure of herpes simplex viruses. 1985; 425–446.
• McNeamey TA, Odell C, Holers VM, et al.: Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement mediated neutralization of viral infectivity. J Exp Med 1987;166:1525–1535.
  Article Google Scholar
• Friedman HM, Wang L, Fishman NO, et al.: Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol 1996;70:4253–4260.
  PubMed CAS Google Scholar
• Johnson DC, Spear PG: O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell 1983;32:987–997.
  Article PubMed CAS Google Scholar
• Tal-Singer R, et al.: Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 1995;69: 4471–4483.
  PubMed CAS Google Scholar
• Fries LF, Friedman HM, Cohen GH, et al.: Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 1986;137: 1636–1641.
  PubMed CAS Google Scholar
• Hung SL, Peng C, Kostavasili I, et al.: The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the altemative complement pathway. Virology 1994;203:299–312.
  Article PubMed CAS Google Scholar
• Kostavasil I, Sahu A, Friedman HM, et al.: Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol 1997;158:1763–1771.
  Google Scholar
• Friedman HM, Wang L, Pangburn MK, et al.: Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1. J Immunol 2000; 165:4528–4536.
  PubMed CAS Google Scholar
• Lubinski JM, Wang L, Soulika AM, et al.: Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol 1998;72:8257–8263.
  PubMed CAS Google Scholar
• Lubinski J, Wang L, Mastellos D, et al.: In vivo role of complement-interacting domains of herpessimplex virus type 1 glycoprotein gC. J Exp Med 1999;190:1637–1646.
  Article PubMed CAS Google Scholar
• Cooper NR: Complement evasion strategies of microorganisms. Immunol Today 1991;12:327–331.
  Article PubMed CAS Google Scholar
• Nemerow GR, Houghten RA, Moore MD, et al.: Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell 1989;56:369–377.
  Article PubMed CAS Google Scholar
• Tsoukas CD, Lambris JD: Expression of EBV/C3d receptors on T cells: biological significance. Immunol Today 1993;14:56–59.
  Article PubMed CAS Google Scholar
• Ross GD, Newman SL, Lambris JD, et al.: Generation of three different fragments of bound C3 with purified factor 1 or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. J Exp Med 1983;158:334–352.
  Article PubMed CAS Google Scholar
• Kalli KR, Ahearn JM, Fearon DT: Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J Immunol 1991;147: 590–594.
  PubMed CAS Google Scholar
• Hedrick JA, Lao Z, Wang Y, et al.: Isolation and characterization of Epstein-Barr Virus receptor from a T cell line (HSB2). J Immunol 1994;153:4418–4426.
  PubMed CAS Google Scholar
• Bergelson JM, Chan M, Solomon KR, et al.: Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchoredcomplement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 1994; 91:6245–6249.
  Article PubMed CAS Google Scholar
• Manchester M, Liszewski MK, Atkinson JP, et al.: Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci USA 1994;91:2161–2165.
  Article PubMed CAS Google Scholar
• Smith LC, Azumi K, Nonaka M: Complement systems in invertebrates. The ancient talternative and lectin pathways. Immunopharmacology 1999;42:107–120.
  Article PubMed CAS Google Scholar
• Day NKB, Gewurz H, Johansen R, et al.: Complement and complement-like activity in lower vertebrates and invertebrates. J Exp Med 1970;132:941–950.
  Article PubMed CAS Google Scholar
• Al-Sharif WZ, Sumyer JO, Lambris JD, et al.: Sea urchin coelomocytes specifically express a homoloque of the complement component C 3. J Immunol 1997; 160: 2983–2997.
  Google Scholar
• Sunyer JO, Zarkadis IK, Sahu A, et al.: Multiple forms of complement C3 in trout, that differerin binding to complement tactivators. Proc Natl Acad Sci USA 1996;93: 8546–8551.
  Article PubMed CAS Google Scholar
• Sunyer JO, Tort L, Lambris JD: Structural C3 diversity in fish—Characterization of five forms of C3 in the diploid fish Spansaurata. J Immunol 1997;158:2813–2821.
  PubMed CAS Google Scholar
• Marino R, Kimura Ym De Santis R, et al.: Complement in urochordates: cloning and characterization of two C3-like genes in the ascidian C iona intestinalis. Immunogenetics 2002;53:1055–1064.
  Article PubMed CAS Google Scholar
• Smith SL: Shark complement: an assessment. Immunol Rev 1998; 166:67–78.
  Article PubMed CAS Google Scholar
• Suzuki MM, Satoh N, Nonaka M: C6-like and c3-like molecules from the cephalochordate, amphioxus, suggest a cytolytic complement system invertebrates. J Mol Evol 2002;54:671–679.
  Article PubMed CAS Google Scholar
• Franchini S, Zarkadis IK, Syfroera G, et al.: Cloning and purification of the rainbow trout fifth component of compoement (C5). Dev Comp Immunol 2001;25: 419–430.
  Article PubMed CAS Google Scholar
• Miyazawa S, Azumi K, Nonaka M: (2001) Cloning and characterization of integrinal phasubunits from the solitary ascidian, halocynthia roretzi. J Immunol 2001;166: 1710–1715.
  PubMed CAS Google Scholar
• Sunyer JO, Zarkadis I, Sarrias MR, et al.: Cloning, structure, and function of two rainbow trout Bf molecules. Immunol 1998;161: 4106–4114.
  CAS Google Scholar
• Alsenz J, Becherer JD, Nilsson B, et al.: Structural and functional analysis of C3 using monoclonal antibodies. Curr Top Microbiol Immunol 1989;153:235–248.
  Google Scholar
• Kenaper C, Zipfel PF, Gigli I: The complement cofactor protein (SBP1) from the barred sand bass Paralabrax nebulifer) mediates overlapping regulatory activities of both human C4b binding protein and factor H. J Biol Chem 1998;273:19,398–19,404.
  Google Scholar
• Fausto N, Webber EM: Liver Regeneration, in The Liver: Biology and Pathobiology (Arias IM, Boyer JL, Fausto N, et al., eds.). 3rd, ed. Raven Press, New York, 1994;1059–1084.
  Google Scholar
• Cressman DE, Greenbaum LE, DeAngelis RA, et al.: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379–1383.
  Article PubMed CAS Google Scholar
• Yamada Y, Kirillova I, Peschon JJ, et al.: Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor encrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441–1446.
  Article PubMed CAS Google Scholar
• Taub R, Greenbaum LE, Peng Y: Transcriptional regulatory signals define cytokine-dependent and-independent pathways in liver regeneration. Semin Liver Dis 1999;19:117–127.
  Article PubMed CAS Google Scholar
• Finch AM, Wong AK, Packowski NJ, et al.: Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem 1999;42: 1965–1974.
  Article PubMed CAS Google Scholar
• Brockes JP: Amphibian limb regeneration: rebuilding a complex structure. Science 1997;276: 81–87.
  Article PubMed CAS Google Scholar
• Tsonis PA: Amphibian limb regeneration In vivo. 1991;5:541–550.
  PubMed CAS Google Scholar
• Tsonis PA: Regeneration in vereebrates. Dev Biol 2000;221: 273–284.
  Article PubMed CAS Google Scholar
• Del Rio-Tsonis K, Tsonis PA, Zarkadis IK, et al.: Expression of the third component of complement, C3, in regeneting limb blastema cells of urodeles. J Immunol 1998;161:6819–6824.
  PubMed Google Scholar
• Sun X, Funk CD, Deng C, et al.: Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci USA 1999;96: 628–633.
  Article PubMed CAS Google Scholar
• Petrenko O, Beavis A, Klaine M, et al.: The molecular characterization of the fetal stem cell marker AA4. Immunity 1999;10:691–700.
  Article PubMed CAS Google Scholar
• Dean YD, McGreal EP, Gasque P.: Endothelial cells, megakaryoblasts, paltelets and alveolar epithelial cells express abundant levels of the mouse AA4 antigen, a C-type lectin-like receptor involved in homing activities and innate immune host defense. Eur J Immunol 2001;31:1370–1381.
  Article PubMed CAS Google Scholar
• Zou YR, Kottmann AH, Kuroda M, et al.: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393: 595–599.
  Article PubMed CAS Google Scholar